Remove Compounding Remove Drug Development Remove Labelling
article thumbnail

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

Particularly beneficial in the early drug discovery phase, AI can help identify potential drug targets more effectively than traditional methods, accelerating the initial stages of drug development by quickly sifting through large volumes of data.

article thumbnail

Collaboration with Janssen and Eli Lilly to address lack of paediatric medications

Pharmaceutical Technology

Therefore, with an inadequate or loss of response to these anti-TNFs, clinicians must prescribe adult therapies off-label to treat younger patients. These developments were compounded by Lilly’s announcement that it has discontinued development of mirikizumab for psoriasis in April of last year. Ther Innov Regul Sci.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novartis’ Pluvicto presents survival benefit for castration-resistant prostate cancer

pharmaphorum

Pluvicto becomes the first PSMA-targeted intravenous radioligand therapy – combining a targeting compound or ligand with a therapeutic radionuclide or radioactive particle (in this case, lutetium-177) – to demonstrate clinical benefit in mCRPC patients before receiving taxane-based chemotherapy.

article thumbnail

Metaverse or Virtual Reality? What is the Difference?

Pulses

References Ley D, Parkes D, Walton G. 6-emerging technologies for learning.

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. The worldwide trend of using botanical drugs and strategies for developing global drugs.

article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

At the same time, the NHC recommends that CMS avoid incorporating the MFP into ASP calculations, as doing so could depress reimbursement rates across both Medicare and commercial markets, compounding access risks and straining provider viability. A first priority is clarifying how providers should submit claims for drugs subject to the MFP.

article thumbnail

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmaTech

Thakar Varanya Chaiyaperm View All News Article Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling. Calculations provide the amount of drug specified in the medication order needed for compounding; it is the objective of the medication order.